Personalized cancer vaccines: Delivery breakthrough may provide better results
Tuesday, February 11, 2020 - 08:00
in Health & Medicine
The only therapeutic cancer vaccine available on the market has so far showed very limited efficacy in clinical trials. EPFL researchers are currently working on an alternative. They have developed a platform that allows a cancer vaccine to be delivered to a precise location and stimulate the immune system in a safe way—thereby overcoming one of the two obstacles to creating an effective vaccine.